|418.65||+5.44||+1.32%||Vol 491.25K||1Y Perf 20.24%|
|Apr 13th, 2021 15:46 DELAYED|
|- -%||- -|
|Target Price||468.38||Analyst Rating||Strong Buy 1.43|
|Potential %||11.87||Finscreener Ranking||★★★★ 53.99|
|Insiders Trans % 3/6/12 mo.||-60/-89/-90||Value Ranking||★★★+ 53.09|
|Insiders Value % 3/6/12 mo.||-98/-100/-100||Growth Ranking||★★★★+ 65.65|
|Insiders Shares Cnt. % 3/6/12 mo.||-98/-100/-100||Income Ranking||★★ 40.32|
|Market Cap||54.01B||Earnings Rating||Strong Buy|
|Price Range Ratio 52W %||56.80||Earnings Date||28th Apr 2021|
Today's Price Range
5 Year PE Ratio Range
|Moving Averages:||Strong Buy|
|Earnings History||Estimate||Reported||Surprise %|
|Earnings Per End||Estimate||Revision %||Trend|
|Next Report Date||28th Apr 2021|
|Estimated EPS Next Report||7.21|
|EPS Growth Next 5 Years %||12.10|
|Avg. Weekly Volume||691.26K|
|Avg. Monthly Volume||901.06K|
|Avg. Quarterly Volume||1.07M|
Humana Inc. (NYSE: HUM) stock closed at 413.21 per share at the end of the most recent trading day (a -1.08% change compared to the prior day closing price) with a volume of 790.04K shares and market capitalization of 54.01B. Is a component of S&P 500, Russell 1000 indices and it is traded on NYSE exchange. The company belongs in the Healthcare Plans industry, Healthcare sector and employs 48700 people. Humana Inc. CEO is Bruce D. Broussard.
The one-year performance of Humana Inc. stock is 20.24%, while year-to-date (YTD) performance is 0.72%. HUM stock has a five-year performance of 143.52%. Its 52-week range is between 344.95 and 474.7, which gives HUM stock a 52-week price range ratio of 56.80%
Humana Inc. currently has a PE ratio of 16.10, a price-to-book (PB) ratio of 3.83, a price-to-sale (PS) ratio of 0.92, a price to cashflow ratio of 9.60, a PEG ratio of 2.32, a ROA of 10.11%, a ROC of -% and a ROE of 25.10%. The company’s profit margin is 5.06%, its EBITDA margin is -%, and its revenue ttm is $58.22 Billion , which makes it $451.27 revenue per share.
Of the last four earnings reports from Humana Inc., there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $7.21 for the next earnings report. Humana Inc.’s next earnings report date is 28th Apr 2021.
The consensus rating of Wall Street analysts for Humana Inc. is Strong Buy (1.43), with a target price of $468.38, which is +11.87% compared to the current price. The earnings rating for Humana Inc. stock is Strong Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
Humana Inc. has a dividend yield of 0.68% with a dividend per share of $2.80 and a payout ratio of 7.00%.
Humana Inc. has a Buy technical analysis rating based on Technical Indicators (ADX : 8.66, ATR14 : 11.46, CCI20 : 42.73, Chaikin Money Flow : -0.01, MACD : 3.19, Money Flow Index : 60.65, ROC : -0.35, RSI : 58.48, STOCH (14,3) : 38.67, STOCH RSI : 0.69, UO : 45.46, Williams %R : -61.33), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of Humana Inc. in the last 12-months were: Brian A. Kane (Option Excercise at a value of $6 521 363), Brian A. Kane (Sold 49 153 shares of value $21 884 216 ), Bruce D. Broussard (Option Excercise at a value of $15 649 946), Bruce D. Broussard (Sold 92 148 shares of value $39 561 859 ), Christopher H. Hunter (Option Excercise at a value of $3 197 087), Christopher H. Hunter (Sold 16 904 shares of value $7 502 650 ), Cynthia H. Zipperle (Option Excercise at a value of $0), Cynthia H. Zipperle (Sold 1 000 shares of value $443 582 ), David A. Jones (Sold 5 000 shares of value $1 963 800 ), Heather M. Carroll Cox (Option Excercise at a value of $0), John W. Garratt (Option Excercise at a value of $0), Jorge S. Mesquita (Buy at a value of $151 263), Joseph C. Ventura (Option Excercise at a value of $0), Karen W. Katz (Option Excercise at a value of $0), Marissa T. Peterson (Sold 2 492 shares of value $996 526 ), Samir Deshpande (Option Excercise at a value of $0), Susan M. Diamond (Option Excercise at a value of $0), Susan M. Diamond (Sold 1 580 shares of value $594 115 ), Timothy Alan Wheatley (Option Excercise at a value of $2 965 380), Timothy Alan Wheatley (Sold 15 259 shares of value $6 818 540 ), Timothy S. Huval (Option Excercise at a value of $1 319 361), Timothy S. Huval (Sold 8 685 shares of value $3 621 577 ), Vishal Agrawal (Option Excercise at a value of $0), Wayne A.I. Frederick (Option Excercise at a value of $0), William H Shrank (Option Excercise at a value of $0), William Kevin Fleming (Option Excercise at a value of $2 772 041), William Kevin Fleming (Sold 16 611 shares of value $7 133 214 )
Copyright © 2016-2021 Finscreener.org. All Rights Reserved.
Disclaimer: Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex and Tradegate data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.org, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
This could take some time, please wait.